| Stage | ACT | % of rev | MLI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $317M | 100.00% | $1.4B | 100.00% | MLI ×4.47 |
| Gross profit | $284M | 89.52% | $361M | 25.48% | ACT +64.0pp |
| Operating income | $232M | 73.26% | $282M | 19.85% | ACT +53.4pp |
| Pre-tax income | $220M | 69.32% | $299M | 21.09% | ACT +48.2pp |
| Net income | $175M | 55.10% | $224M | 15.81% | ACT +39.3pp |
| Stage | ACT | MLI | Gap · A − B |
|---|---|---|---|
| Revenue | $317M100.00% | $1.4B100.00% | MLI ×4.47 |
| Gross profit | 89.52%$284M | 25.48%$361M | ACT +64.0pp |
| Operating income | 73.26%$232M | 19.85%$282M | ACT +53.4pp |
| Pre-tax income | 69.32%$220M | 21.09%$299M | ACT +48.2pp |
| Net income |
| 55.10%$175M |
| 15.81%$224M |
| ACT +39.3pp |
No disclosed counterparties: MLI.
None